164 related articles for article (PubMed ID: 36870381)
1. Cardiac index: A superior parameter of cardiac function than left ventricular ejection fraction in risk stratification of hypertrophic cardiomyopathy.
Zhang Y; Zhu Y; Wang D; Xu L; Jiang W; Wang J; Sun X; Kang L; Song L
Heart Rhythm; 2023 Jul; 20(7):958-967. PubMed ID: 36870381
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
Choi YJ; Kim HK; Hwang IC; Park CS; Rhee TM; Lee HJ; Park JB; Yoon YE; Lee SP; Cho GY; Kim YJ
Heart; 2023 Apr; 109(10):771-778. PubMed ID: 36581445
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular global longitudinal strain as a prognosticator in hypertrophic cardiomyopathy with a low-normal left ventricular ejection fraction.
Choi YJ; Lee HJ; Park JS; Park CS; Rhee TM; Choi JY; Choi HM; Park JB; Yoon YE; Lee SP; Na JO; Cho GY; Kim YJ; Hwang IC; Kim HK
Eur Heart J Cardiovasc Imaging; 2023 Sep; 24(10):1374-1383. PubMed ID: 37467475
[TBL] [Abstract][Full Text] [Related]
4. Supplementary role of left ventricular global longitudinal strain for predicting sudden cardiac death in hypertrophic cardiomyopathy.
Lee HJ; Kim HK; Lee SC; Kim J; Park JB; Hwang IC; Choi YJ; Lee SP; Chang SA; Lee W; Park EA; Cho GY; Kim YJ
Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1108-1116. PubMed ID: 34542591
[TBL] [Abstract][Full Text] [Related]
5. Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians.
Choi YJ; Kim HK; Lee SC; Park JB; Moon I; Park J; Kim YJ; Sohn DW; Ommen S
Heart; 2019 Dec; 105(24):1892-1897. PubMed ID: 31383719
[TBL] [Abstract][Full Text] [Related]
6. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
[TBL] [Abstract][Full Text] [Related]
7. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy.
Liu J; Wu G; Zhang C; Ruan J; Wang D; Zhang M; Wang L; Yang Y; Li X; Wang Y; Hui R; Zou Y; Kang L; Wang J; Song L
Heart Rhythm; 2020 Oct; 17(10):1658-1663. PubMed ID: 32311532
[TBL] [Abstract][Full Text] [Related]
8. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
[No Abstract] [Full Text] [Related]
9. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy.
Wu G; Liu J; Wang S; Yu S; Zhang C; Wang D; Zhang M; Yang Y; Kang L; Zhao S; Hui R; Zou Y; Wang J; Song L
Heart; 2021 Oct; 107(19):1576-1583. PubMed ID: 33361398
[TBL] [Abstract][Full Text] [Related]
11. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
Gulati A; Jabbour A; Ismail TF; Guha K; Khwaja J; Raza S; Morarji K; Brown TD; Ismail NA; Dweck MR; Di Pietro E; Roughton M; Wage R; Daryani Y; O'Hanlon R; Sheppard MN; Alpendurada F; Lyon AR; Cook SA; Cowie MR; Assomull RG; Pennell DJ; Prasad SK
JAMA; 2013 Mar; 309(9):896-908. PubMed ID: 23462786
[TBL] [Abstract][Full Text] [Related]
12. Additive prognostic significance of ejection fraction for ESC risk model in hypertrophic cardiomyopathy patients.
Hen Y; Iguchi N; Kanisawa M; Takada K; Machida H; Takara A; Teraoka K; Takamisawa I; Takayama M; Yoshikawa T
Heart Vessels; 2020 Mar; 35(3):391-398. PubMed ID: 31482217
[TBL] [Abstract][Full Text] [Related]
13. [The value of cardiac MRI in the risk stratification in patients with hypertrophic cardiomyopathy].
Wang JX; Yang SJ; Ma X; Yu SQ; Dong ZX; Xiang XR; Wei ZX; Cui C; Yang K; Chen XY; Lu MJ; Zhao SH
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jun; 51(6):619-625. PubMed ID: 37312480
[No Abstract] [Full Text] [Related]
14. Validation of the Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy.
Qi W; Pu L; Zhang J; Chen H; Tang Z; Wang J; Han Y; Chen Y
Curr Probl Cardiol; 2023 Nov; 48(11):101875. PubMed ID: 37331610
[TBL] [Abstract][Full Text] [Related]
15. Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
Lyons KS; Dixon LJ; Johnston N; Noad R; Hamilton A; McKeag N; Horan P
Cardiol J; 2014; 21(1):29-32. PubMed ID: 23990187
[TBL] [Abstract][Full Text] [Related]
16. Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; de Groot NM; van Domburg RT; Ten Cate FJ; Michels M
Clin Cardiol; 2014 Aug; 37(8):493-8. PubMed ID: 25044226
[TBL] [Abstract][Full Text] [Related]
17. Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy.
Zegkos T; Tziomalos G; Parcharidou D; Ntelios D; Papanastasiou CA; Karagiannidis E; Gossios T; Rouskas P; Katranas S; Paraskevaidis S; Karvounis H; Efthimiadis G
Hellenic J Cardiol; 2022; 63():15-21. PubMed ID: 34147674
[TBL] [Abstract][Full Text] [Related]
18. Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy.
Magrì D; Limongelli G; Re F; Agostoni P; Zachara E; Correale M; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Musumeci B; Maruotti A; Volpe M; Autore C
Heart; 2016 Apr; 102(8):602-9. PubMed ID: 26849900
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.
Norrish G; Ding T; Field E; Cervi E; Ziółkowska L; Olivotto I; Khraiche D; Limongelli G; Anastasakis A; Weintraub R; Biagini E; Ragni L; Prendiville T; Duignan S; McLeod K; Ilina M; Fernández A; Marrone C; Bökenkamp R; Baban A; Kubus P; Daubeney PEF; Sarquella-Brugada G; Cesar S; Klaassen S; Ojala TH; Bhole V; Medrano C; Uzun O; Brown E; Gran F; Sinagra G; Castro FJ; Stuart G; Vignati G; Yamazawa H; Barriales-Villa R; Garcia-Guereta L; Adwani S; Linter K; Bharucha T; Garcia-Pavia P; Siles A; Rasmussen TB; Calcagnino M; Jones CB; De Wilde H; Kubo T; Felice T; Popoiu A; Mogensen J; Mathur S; Centeno F; Reinhardt Z; Schouvey S; O'Mahony C; Omar RZ; Elliott PM; Kaski JP
Circ Arrhythm Electrophysiol; 2022 May; 15(5):e010075. PubMed ID: 35491873
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy.
Magri D; Agostoni P; Sinagra G; Re F; Correale M; Limongelli G; Zachara E; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Morosin M; Musumeci B; Pagannone E; Maruotti A; Uguccioni M; Volpe M; Autore C
Int J Cardiol; 2018 Nov; 271():125-131. PubMed ID: 30087038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
